EDPB and AMLA Plan Joint Guidance on AML Data Sharing
EDPB and AMLA will prepare guidance on GDPR-compliant AML information-sharing partnerships before Article 75 AMLR applies in July 2027.
EDPB and AMLA will prepare guidance on GDPR-compliant AML information-sharing partnerships before Article 75 AMLR applies in July 2027.
The EDPB ruled that a GDPR complaint about cookie banners must be assessed on its merits, rejecting claims of abuse of rights by the complainant.
The EDPB introduces new tools and cooperation efforts to simplify GDPR compliance, support innovation, and ensure consistent data protection enforcement across Europe.
The EDPB adopted a common data breach notification template to simplify GDPR reporting, improve consistency, and support faster responses across Europe.
The EDPB met with Commissioner McGrath to discuss GDPR priorities, cross-regulatory cooperation, children’s data protection, andpolitical ads.
The EDPB approved Europrivacy certification for global use, enhancing GDPR compliance and simplifying international data transfers with stronger legal safeguards.
The EDPB has released a DPIA template to help organizations comply with GDPR by structuring and simplifying risk assessments, now open for public feedback until 9 June.
The EDPB’s 2025 Annual Report highlights increased GDPR enforcement, cross-border cooperation, guidance on new technologies, and €300 million in fines for data protection violations.
The EDPB issued guidelines to clarify GDPR compliance for scientific research, covering consent, data subject rights, responsibilities, and technical safeguards.
The EDPB’s 2026 Coordinated Enforcement Framework targets GDPR transparency obligations, with 25 DPAs assessing compliance and sharing findings for EU-wide improvements.
The EDPB and EDPS jointly support enhanced cybersecurity laws in Europe, emphasizing coordination with data protection rules and simplifying breach notifications.
The EDPB and EDPS support the European Biotech Act proposal while urging strong data protection measures for clinical trial participants and clear legal roles under GDPR.